Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
HTX | healthlinks | 09/08/16 | 4 | 954 | |||
|
|||||||
HTX | Opening Price | 26/05/15 | 15 | 4.2K | |||
|
|||||||
HTX | Ann: Change of ASX Code to MTL | 17/03/15 | 0 | 642 | |||
|
|||||||
HTX | Ann: Becoming a substantial holder | 17/03/15 | 0 | 451 | |||
|
|||||||
HTX | Ann: Becoming a substantial holder | 17/03/15 | 0 | 406 | |||
|
|||||||
HTX | Ann: Initial Director's Interest Notice | 17/03/15 | 0 | 413 | |||
|
|||||||
HTX | Ann: Initial Director's Interest Notice | 17/03/15 | 0 | 410 | |||
|
|||||||
HTX | Ann: Initial Director's Interest Notice | 17/03/15 | 0 | 252 | |||
|
See All Discussions